World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 30992884

Number of visits today: 2847

Number of downloads: 13527891

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Uchida K, Koike Y, Hashimoto K, Saigusa S, Inoue M, Otake K, Tanaka K, Matsushita K, Okita Y, Fujikawa H, Araki T, Mohri Y, Kusunoki M. The Increased Expression of CCL20 and CCR6 in Rectal Mucosa Correlated to Severe Inflammation in Pediatric Ulcerative Colitis. Gastroenterol Res Pract 2015;2015:856532. [PMID: 25691899 DOI: 10.1155/2015/856532] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]

For:

Uchida K, Koike Y, Hashimoto K, Saigusa S, Inoue M, Otake K, Tanaka K, Matsushita K, Okita Y, Fujikawa H, Araki T, Mohri Y, Kusunoki M. The Increased Expression of CCL20 and CCR6 in Rectal Mucosa Correlated to Severe Inflammation in Pediatric Ulcerative Colitis. Gastroenterol Res Pract 2015;2015:856532. [PMID: 25691899 DOI: 10.1155/2015/856532] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]

Number	Citing Articles
1	Dutta P, Ta A, Thakur BK, Dasgupta N, Das S. Biphasic Ccl20 regulation by Toll-like receptor 9 through the activation of ERK-AP-1 and non-canonical NF-κB signaling pathways. Biochim Biophys Acta Gen Subj 2017;1861:3365-77. [PMID: 27590109 DOI: 10.1016/j.bbagen.2016.08.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2	Meitei HT, Jadhav N, Lal G. CCR6-CCL20 axis as a therapeutic target for autoimmune diseases. Autoimmun Rev 2021;20:102846. [PMID: 33971346 DOI: 10.1016/j.autrev.2021.102846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3	Lee JC, Park GR, Choi BS, Lee Y, Han CH. Restoration of the inflammatory gene expression by horse oil in DNCB-treated mice skin. J Vet Sci 2020;21:e15. [PMID: 31940694 DOI: 10.4142/jvs.2020.21.e15] [Reference Citation Analysis]
4	Park JH, Jeong DY, Peyrin-Biroulet L, Eisenhut M, Shin JI. Insight into the role of TSLP in inflammatory bowel diseases. Autoimmun Rev 2017;16:55-63. [PMID: 27697608 DOI: 10.1016/j.autrev.2016.09.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
5	Ranasinghe R, Eri R. CCR6–CCL20 Axis in IBD: What Have We Learnt in the Last 20 Years? GastrointestDisord 2018;1:57-74. [DOI: 10.3390/gidisord1010006] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6	Cheng F, Li Q, Wang J, Zeng F, Wang K, Zhang Y. Identification of Differential Intestinal Mucosa Transcriptomic Biomarkers for Ulcerative Colitis by Bioinformatics Analysis. Dis Markers 2020;2020:8876565. [PMID: 33144895 DOI: 10.1155/2020/8876565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7	Long Y, Zhao X, Xia C, Li X, Fan C, Liu C, Wang C. Upregulated IL‐17A secretion and CCR6 co‐expression in Treg subsets are related to the imbalance of Treg/Th17 cells in active UC patients. Scand J Immunol 2020;91. [DOI: 10.1111/sji.12842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]